NCT02062502
Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063) prevention 3 completed NCT00029484
Tai Chi Chih and Varicella Zoster Immunity No drug interventions Not Available 2 completed NCT05952505
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines prevention 4 not_yet_recruiting NCT00384397
A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers prevention 3 completed NCT01190228
Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV prevention 3 completed NCT00975507
ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) prevention 3 completed NCT00822237
Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed) prevention 3 completed NCT03843632
Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058) prevention 3 completed NCT00892775
Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds prevention 2 completed NCT00432042
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) prevention 3 completed NCT02173899
Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine prevention 4 completed NCT01991899
Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. No drug interventions health_services_research 3 completed NCT00226499
Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox prevention 3 completed NCT00969436
Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM prevention 3 completed NCT00926419
Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery prevention 2 / 3 unknown_status NCT01738841
Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines Not Available Not Available withdrawn NCT00715234
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients No drug interventions prevention Not Available completed NCT00568334
Study of Two Formulations of GSK Biologicals' Varicella Vaccine prevention 2 completed NCT06314724
Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines prevention 3 enrolling_by_invitation NCT06482216
Correlation of Protection Against Varicella in an Exploratory Study Not Available Not Available not_yet_recruiting NCT00169416
Evaluation Of Valaciclovir In Patients With Chickenpox treatment 3 completed NCT06484686
An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine prevention 4 not_yet_recruiting NCT05015686
Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old prevention 3 enrolling_by_invitation NCT00492739
Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients treatment 2 / 3 recruiting NCT05669625
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine prevention 3 active_not_recruiting NCT00258726
Immune Responses to Two Dose Varivax +/- MMR-II prevention 1 / 2 terminated NCT00985166
A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) prevention 3 completed NCT05526820
A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine prevention 4 completed NCT00402831
ProQuad® Intramuscular vs Subcutaneous prevention 3 completed NCT03239873
Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03) prevention 3 completed NCT00566527
Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) prevention 3 completed NCT01626794
A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062) prevention 3 withdrawn NCT05095701
An Immunity Persistence Study of Live Attenuated Varicella Vaccine prevention 4 enrolling_by_invitation NCT05839301
A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age prevention 3 active_not_recruiting NCT00092404
Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) prevention 2 completed NCT02146469
Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine prevention 4 unknown_status NCT00984295
Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines prevention 3 completed NCT05470855
Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province prevention 4 unknown_status NCT00560755
Safety Study of ProQuad® rHA in Infants (V221-037) prevention 3 completed NCT00138255
Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines No drug interventions Not Available Not Available terminated NCT00351923
Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes No drug interventions prevention 3 completed NCT00127608
Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients No drug interventions prevention 3 completed NCT05422508
Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination other 2 recruiting NCT03114943
Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age prevention 3 completed NCT00985153
Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) prevention 3 completed NCT05158777
Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old prevention 3 completed NCT00352898
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ prevention 2 completed NCT01536405
Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) prevention 3 completed NCT00126997
Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases treatment 4 completed NCT01830283
The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination prevention 4 unknown_status NCT01062061
Re-examination Study For Varivax (V210-059 AM2) Not Available Not Available completed NCT00406211
Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine prevention 3 completed NCT01506193
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children prevention 3 completed NCT04471493
Pediatric and Ambulatory Research in Infectious Diseases No drug interventions Not Available Not Available recruiting NCT03555071
A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine No drug interventions prevention 3 completed NCT03330171
Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine prevention 4 unknown_status NCT00353288
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ prevention 2 completed NCT00986232
ProQuad Dose Selection Study (V221-011)(COMPLETED) prevention 2 completed NCT00578175
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age prevention 2 completed NCT00338442
Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection Not Available Not Available approved_for_marketing NCT02981836
A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines prevention 3 completed NCT00839917
A Study of ProQuad™ in Healthy Children in Korea (V221-023) prevention 3 terminated NCT00092430
Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) prevention 3 completed NCT00830648
Safety of a Second Dose of Biken's Varicella Vaccine prevention 4 completed NCT00751348
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 prevention 3 completed NCT01390857
Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox) Not Available Not Available completed NCT02692066
Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine. Not Available Not Available withdrawn NCT01866566
The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination prevention 4 unknown_status NCT00483574
Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers prevention 3 completed NCT03114982
The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age prevention 2 completed NCT00432731
Safety Study of a Refrigerator-stable Formulation of VARIVAX® Not Available 4 completed NCT00496327
Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056) prevention 3 completed NCT00092391
A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) prevention 3 completed NCT05460429
Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus prevention 4 unknown_status NCT05150392
An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization prevention 3 completed NCT00422292
Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers prevention 3 completed NCT01077804
A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED) No drug interventions Not Available Not Available completed NCT02965404
A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children prevention 1 completed NCT00127010
Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases prevention 3 completed NCT00432523
Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011) Not Available 3 completed NCT00792623
Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). prevention 2 completed NCT00127023
Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases prevention 3 completed NCT06068608
A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy prevention 1 recruiting NCT00109343
V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) prevention 3 completed